Janssen has announced that its therapy Stelara (ustekinumab) hass secured a label expansion from the European Commission, approving the drug in the treatment of moderately to severely active ulcerative colitis (UC)...
Latest articles
FDA approves first drug to treat patients with rare lung condition
The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or...
How to Develop a Content Strategy: Start With These 3 Questions
If your content doesn’t connect with an audience, success isn’t an option. But to get the audience, you first must answer these three essential questions. And use these resources to create an effective content marketing...
Got a Plan? Content Marketing Success Demands It
Not all of us control our brand’s content strategy. Our job is to develop the tactical plan – policies, processes, resources, and task-related decisions. Read on for a handy tutorial with the resources to make...
‘Kunstmatig blad’ produceert voor het eerst medicijnen met zonlicht
Medicijnen goedkoop en overal kunnen produceren, met zonlicht als energiebron. Die realiteit is dichterbij dan ooit nu chemici van de TU Eindhoven een ‘mini-reactor’ presenteren die, vergelijkbaar met bladeren in de...
Ofatumumab Bests Teriflunomide in Head-to-Head MS Trials
Findings from the phase 3 ASCLEPIOS I and II studies showed that treatment with ofatumumab (Novartis), a CD20-directed cytolytic monoclonal antibody, resulted in a highly significant and clinically meaningful reduction...
